Kelly Jabar, a former FDA civil servant, testified during the public comment period that she was terminated by HHS amid cancer treatment and that agency personnel actions and mailings exposed sensitive information. She described a confusing back-and-forth of rescinded and later finalized terminations, lack of communication from supervisors and managers, and receipt of an unsealed SF-50 containing sensitive data.